Cogent Biosciences, Inc.
COGT
$5.08
$0.3557.52%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -71.99M | -67.93M | -70.63M | -58.95M | -58.35M |
| Total Depreciation and Amortization | 1.14M | 1.11M | 1.10M | 1.08M | 1.07M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.05M | 7.37M | 4.16M | 12.59M | 8.00M |
| Change in Net Operating Assets | -4.72M | -1.13M | 13.40M | 2.58M | -3.24M |
| Cash from Operations | -66.51M | -60.58M | -51.98M | -42.70M | -52.53M |
| Capital Expenditure | -547.00K | -75.00K | -280.00K | -148.00K | -70.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 69.93M | 61.75M | 60.47M | -84.48M | 1.11M |
| Cash from Investing | 69.38M | 61.67M | 60.19M | -84.63M | 1.04M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 24.97M | 126.00K | 624.00K | 11.34M | 214.06M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 11.50M | 0.00 | -11.60M | -- |
| Cash from Financing | 24.97M | 26.00K | 624.00K | -256.00K | 214.06M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 27.84M | 1.12M | 8.83M | -127.58M | 162.57M |